Compare VALN & KRSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VALN | KRSP |
|---|---|---|
| Founded | 2012 | 2025 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 536.9M | 474.3M |
| IPO Year | 2021 | N/A |
| Metric | VALN | KRSP |
|---|---|---|
| Price | $5.43 | $10.37 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $15.50 | N/A |
| AVG Volume (30 Days) | ★ 92.8K | 67.7K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $93.87 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.15 | $10.21 |
| 52 Week High | $12.25 | $10.70 |
| Indicator | VALN | KRSP |
|---|---|---|
| Relative Strength Index (RSI) | 29.03 | 61.06 |
| Support Level | $5.15 | $10.30 |
| Resistance Level | $6.42 | $10.39 |
| Average True Range (ATR) | 0.25 | 0.03 |
| MACD | 0.10 | 0.01 |
| Stochastic Oscillator | 18.11 | 92.31 |
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.
Rice Acquisition Corp 3 is a blank check company.